a method for treating Autism or Autism Spectrum Disorder (ASD) in a subject having, suspected of having, or at risk of developing, Autism or ASD comprising: optionally, subjecting the subject to testing to determine Autism or ASD status of the subject, thereby identifying the subject as being in need of treatment
R.ChisholmD
The rate limiting amino acid in de novo synthesis of GSH in metabolic disease appears to be glycine
doi: 10.3390/cells11223632 Summary Keywords cancer, drug resistance, tumor microenvironment (TME), molecular mechanisms, artificial intelligence (AI), precision oncology, drug sensitivity profiling, therapeutic strategies Citation Xu H, Lu J, Wu J, Zhang K, Zhou X, Gao Z, Feng J, Zhuang Z and Zhong X (2025) Integrated molecular and microenvironmental drivers of drug resistance in gastrointestinal cancers: mechanisms, immunotherapy challenges, and precision strategies